CuraTeQ Biologics Ends Licensing Agreement With BioFactura for Ustekinumab Biosimilar
CuraTeQ Biologics Private Limited, the biologics-focused subsidiary of Aurobindo Pharma Limited, has decided to mutually terminate its licensing agreement with […]
USTEKINUMAB-BIOSIMILAR
